Post-transcriptional control of neurofilaments: New roles in development, regeneration and neurodegenerative disease

Trends in Neurosciences

Volumn 33, Issue 1, 2010, Pages 27-37

  Szaro, Ben G ^a   Strong, Michael J ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERNEXIN; BETA TUBULIN; ELONGATION FACTOR 1ALPHA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; MESSENGER RNA; NEUROFILAMENT M PROTEIN; NEUROFILAMENT PROTEIN; NEUROMODULIN; PERIPHERIN; PROTEIN P21; VIMENTIN;

3' UNTRANSLATED REGION; AGING; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; GENETIC TRANSCRIPTION; HUMAN; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NEUROFILAMENT; NONHUMAN; OPERON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; RNA STABILITY; RNA TRANSLATION; RNA TRANSPORT;

ANIMALS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; NERVE REGENERATION; NEURODEGENERATIVE DISEASES; NEUROFILAMENT PROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER;

EID: 73449137883     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2009.10.002     Document Type: Review

References (109)

1. Coulombe P.A., et al. The 'ins' and 'outs' of intermediate filament organization. Trends Cell Biol. 10 (2000) 420-428
2. Perrot R., et al. Review of the multiple aspects of neurofilament functions and their possible contribution to neurodegeneration. Mol. Neurobiol. 38 (2008) 27-65
3. Walker K.L., et al. Loss of neurofilaments alters axonal growth dynamics. J. Neurosci. 21 (2001) 9655-9666
4. Goldman R.D., et al. Intermediate filaments: versatile building blocks of cell structure. Curr. Opin. Cell Biol. 20 (2008) 28-34
5. Strong M.J., et al. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy? J. Neuropathol. Exp. Neurol. 64 (2005) 649-664
6. Xiao S., et al. Neuronal intermediate filaments and ALS: a new look at an old question. Biochim. Biophys. Acta 1762 (2006) 1001-1012
7. Cañete-Soler R., and Schlaepfer W.W. The complex relation between genotype and phenotype in motor neuron disease. Ann. Neurol. 62 (2007) 8-14
8. Lee M.K., et al. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 13 (1994) 975-988
9. Asch W.S., and Schechter N. Plasticin, a type III neuronal intermediate filament protein, assembles as an obligate heteropolymer: implications for axonal flexibility. J. Neurochem. 75 (2000) 1475-1486
10. Ching G.Y., and Liem R.K. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J. Cell Biol. 122 (1993) 1323-1335
11. Lee M.K., et al. Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122 (1993) 1337-1350
12. Carter J., et al. Neurofilament (NF) assembly; divergent characteristics of human and rodent NF-L subunits. J. Biol. Chem. 273 (1999) 5101-5108
13. Leterrier J.F., and Eyer J. Properties of highly viscous gels formed by neurofilaments in vitro: a possible consequence of a specific inter-filament cross-bridging. Biochem. J. 245 (1987) 93-101
14. Scott D., et al. Characterization of mammalian neurofilament triplet proteins: subunit stoichiometry and morphology of native and reconstituted filaments. J. Biol. Chem. 260 (1985) 10736-10747
15. Chinnakkaruppan A., et al. Age related and hypothyroidism related changes on the stoichiometry of neurofilament subunits in the developing rat brain. Int. J. Dev. Neurosci. 27 (2009) 257-261
16. Chien C.-L., et al. Alpha-internexin is the only neuronal intermediate filament expressed in developing cerebellar granule neurons. J. Neurobiol. 29 (1996) 304-318
17. Goldstein M.E., et al. NF-L and peripherin immunoreactivities define distinct classes of rat sensory ganglion cells. J. Neurosci. Res. 30 (1991) 92-104
18. Charnas L.R., et al. Identification and developmental expression of a novel low molecular weight neuronal intermediate filament protein in Xenopus laevis. J. Neurosci. 12 (1992) 3010-3024
19. Lariviére R.C., and Julien J.-P. Functions of intermediate filaments in neuronal development and disease. J. Neurobiol. 58 (2004) 131-148
20. Brujin L.I., et al. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27 (2004) 723-749
21. Julien J., and Beaulieu J. Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects. J. Neurol. Sci. 180 (2000) 7-14
22. Ching G.Y., and Liem R.K.H. Neuronal intermediate filaments and neurodegenerative diseases. In: Paramio J.M. (Ed). Intermediate Filaments (2006), Landes Bioscience 35-51
23. Thyagarajan A., et al. Post-transcriptional control of neurofilaments in development and disease. Exp. Cell Res. 313 (2007) 2088-2097
24. Troy C.M., et al. Ontogeny of the neuronal intermediate filament protein, peripherin, in the mouse embryo. Neuroscience 36 (1990) 217-237
25. Gervasi C., et al. Xenopus laevis peripherin (XIF3) is expressed in radial glia and proliferating neural epithelial cells as well as in neurons. J. Comp. Neurol. 423 (2000) 512-531
26. Canger A.K., et al. Restricted expression of the neuronal intermediate filament protein plasticin during zebrafish development. J. Comp. Neurol. 399 (1998) 561-572
27. Undamatla J., and Szaro B.G. Differential expression and localization of neuronal intermediate filament proteins within newly developing neurites in dissociated cultures of Xenopus laevis embryonic spinal cord. Cell Motil. Cytoskel. 49 (2001) 16-32
28. Schlaepfer W.W., and Bruce J. Simultaneous up-regulation of neurofilament proteins during the postnatal development of the rat nervous system. J. Neurosci. Res. 25 (1990) 39-49
29. Boyne L.J., et al. Role of vimentin in early stages of neuritogenesis in cultured hippocampal neurons. Int. J. Dev. Neurosci. 14 (1996) 739-748
30. Helfand B.T., et al. A role for intermediate filaments in determining and maintaining the shape of nerve cells. Mol. Biol. Cell 14 (2003) 5069-5081
31. Dubey M., et al. Reexpression of vimentin in differentiated neuroblastoma cells enhances elongation of axonal neurites. J. Neurosci. Res. 78 (2004) 245-249
32. Lee M.K., and Cleveland D.W. Neuronal intermediate filaments. Annu. Rev. Neurosci. 19 (1996) 187-218
33. Leake D., et al. Gefiltin in zebrafish embryos: sequential gene expression of two neurofilament proteins in retinal ganglion cells. Differentiation 65 (1999) 181-189
34. Yuan A., et al. Alpha-internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS. J. Neurosci. 26 (2006) 10006-10019
35. Garcia M.L., et al. NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth. J. Cell Biol. 163 (2003) 1011-1020
36. Kesavapany S., et al. Neurofilaments: phosphorylation and signal transduction. In: Paramio J.M. (Ed). Intermediate Filaments (2006), Springer Science and Business Media 52-73
37. Goldstein M.E., et al. mRNA levels of all three neurofilament proteins decline following nerve transection. Brain Res. 427 (1988) 287-291
38. Oblinger M.M., et al. Axotomy-induced changes in the expression of a type III neuronal intermediate filament. J. Neurosci. 9 (1989) 3766-3775
39. McGraw T.S., et al. Axonally transported peripheral signals regulate alpha-internexin expression in regenerating motoneurons. J. Neurosci. 22 (2002) 4955-4963
40. Mikucki S.A., and Oblinger M.M. Corticospinal neurons exhibit a novel pattern of cytoskeletal gene expression after injury. J. Neurosci. Res. 30 (1991) 213-225
41. Gervasi C., et al. Increased expression of multiple neurofilament mRNAs during regeneration of vertebrate central nervous system axons. J. Comp. Neurol. 461 (2003) 262-275
42. Asch W.S., et al. Cloning of zebrafish neurofilament cDNAs for plasticin and gefiltin: increased mRNA expression in ganglion cells after optic nerve injury. J. Neurochem. 71 (1998) 20-32
43. Jacobs A.J., et al. Recovery of neurofilament expression selectively in regenerating reticulospinal neurons. J. Neurosci. 17 (1997) 5206-5220
44. Liuzzi F.J., and Tedeschi B. Axo-glial interactions at the dorsal root transitional zone regulate neurofilament protein synthesis in axotomized sensory neurons. J. Neurosci. 12 (1992) 4783-4792
45. Zhao Y., and Szaro B.G. The optic tract and tectal ablation influence the composition of neurofilaments in regenerating optic axons of Xenopus laevis. J. Neurosci. 15 (1995) 4629-4640
46. Rodger J., et al. Evidence that regenerating optic axons maintain long-term growth in the lizard Ctenophorus ornatus: growth-associated protein-43 and gefiltin expression. Neuroscience 102 (2001) 647-654
47. Hisanaga S.-I., et al. Morphological and biochemical changes of neurofilaments in aged rat sciatic nerve axons. J. Neurochem. 88 (2004) 735-745
48. Thyagarajan A., and Szaro B.G. Phylogenetically conserved binding of specific KH domain proteins to the 3′ untranslated region of the vertebrate middle neurofilament mRNA. J. Biol. Chem. 279 (2004) 49680-49688
49. Szaro B.G., et al. Squid low molecular weight neurofilament proteins are a novel class of neurofilament protein. J. Biol. Chem. 266 (1991) 15035-15041
50. Way J., et al. A high-molecular-weight squid neurofilament protein contains a lamin-like rod domain and a tail domain of Lys-Ser-Pro repeats. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 6963-6967
51. Weiner O.D., et al. Medium weight neurofilament mRNA in goldfish Mauthner axoplasm. Neurosci. Lett. 213 (1996) 83-86
52. Sotelo-Silveira J.R., et al. Neurofilament mRNAs are present and translated in the normal and severed sciatic nerve. J. Neurosci. Res. 62 (2000) 65-74
53. Sotelo-Silveira J.R., et al. RNA trafficking in axons. Traffic 7 (2006) 508-515
54. Vogelaar C.F., et al. Axonal mRNAs: characterisation and role in the growth and regeneration of dorsal root ganglion axons and growth cones. Mol. Cell. Neurosci. 42 (2009) 102-115
55. Crispino M., et al. Neurofilament proteins are synthesized in nerve endings from squid brain. J. Neurochem. 61 (1993) 1144-1146
56. Koenig E., and Giuditta A. Protein-synthesizing machinery in the axon compartment. Neuroscience 89 (1999) 5-15
57. Kun A., et al. Ribosomal distributions in axons of mammalian myelinated fibers. J. Neurosci. Res. 85 (2007) 2087-2098
58. Willis D.E., et al. Extracellular stimuli specifically regulate localized levels of individual neuronal mRNAs. J. Cell Biol. 178 (2007) 965-980
59. Chang L., et al. Assembling an intermediate filament network by dynamic cotranslation. J. Cell Biol. 172 (2006) 747-758
60. Schwartz M.L., et al. Actinomycin prevents the destabilization of neurofilament mRNA in primary sensory neurons. J. Biol. Chem. 267 (1992) 24596-24600
61. Beaudet L., et al. Different post transcriptional controls for the human neurofilament light and heavy genes in transgenic mice. Mol. Brain Res. 18 (1993) 23-31
62. Thyagarajan A., and Szaro B.G. Dynamic endogenous association of neurofilament mRNAs with K-homology domain ribonucleoproteins in developing cerebral cortex. Brain Res. 1189 (2008) 33-42
63. Moskowitz P.F., and Oblinger M.M. Transcriptional and post-transcriptional mechanisms regulating neurofilament and tubulin gene expression during normal development of the rat brain. Mol. Brain Res. 30 (1995) 211-222
64. Ananthakrishnan L., et al. Dynamic regulation of middle neurofilament (NF-M) RNA pools during optic nerve regeneration. Neuroscience 153 (2008) 144-153
65. Ananthakrishnan L., and Szaro B.G. Transcriptional and translational dynamics of light neurofilament subunit RNAs during Xenopus laevis optic nerve regeneration. Brain Res. 1250 (2009) 27-40
66. Rotshenker S., and Tal M. The transneuronal induction of sprouting and synapse formation in intact mouse muscles. J. Physiol. 360 (1985) 387-396
67. Wong N., et al. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J. Neuropathol. Exp. Neurol. 59 (2000) 972-982
68. Menzies F.M., et al. Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis. J. Neurochem. 82 (2002) 1118-1128
69. Strong M.J., et al. Intermediate filament steady-state mRNA levels in amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 316 (2004) 317-322
70. Ge W.W., et al. Selective loss of trans-acting instability determinants of neurofilament mRNA in amyotrophic lateral sclerosis spinal cord. J. Biol. Chem. 278 (2003) 26558-26563
71. Strong M.J., et al. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol. Cell. Neurosci. 35 (2007) 320-327
72. Ge W.W., et al. 14-3-3 protein binds to the low molecular weight neurofilament (NFL) mRNA 3′UTR. Mol. Cell. Neurosci. 34 (2007) 80-87
73. Ge W.W., et al. Mutant copper/zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA. J. Biol. Chem. 280 (2005) 118-124
74. McLean J.R., et al. Temporal profiles of neuronal degeneration, glial proliferation, and cell death in hNFL+/+ and NFL-/- mice. Glia 52 (2005) 59-69
75. Nie Z., et al. Untranslated element in neurofilament mRNA has neuropathic effect on motor neurons of transgenic mice. J. Neurosci. 22 (2002) 7662-7770
76. Cañete-Soler R., et al. p190RhoGEF binds to a destabilizing element in the 3′UTR of NF-L mRNA and alters the stability of the transcript. J. Biol. Chem. 276 (2001) 32046-32050
77. Cañete-Soler R., et al. Aldolases A and C are ribonucleolytic components of a neuronal complex that regulates the stability of the light neurofilament mRNA. J. Neurosci. 25 (2005) 4353-4364
78. Lin H., et al. RNA-binding protein is involved in aggregation of light neurofilament protein and is implicated in the pathogenesis of motor neuron degeneration. Hum. Mol. Genet. 14 (2005) 3643-3659
79. Volkening K., et al. Human low molecular weight neurofilament (NFL) mRNA interacts with a predicted p190RhoGEF homologue (RGNEF). Amyotroph. Lateral Scler. Jun 1 (2009) 1-7
80. Stefanizzi I., and Cañete-Soler R. Coregulation of light neurofilament mRNA by poly(A)-binding protein and aldolase C: implications for neurodegeneration. Brain Res. 1139 (2007) 15-28
81. Schwartz E.I. Potential application of RNAi for understanding and therapy of neurodegenerative diseases. Front. Biosci. 14 (2009) 297-320
82. Pfister E.L., et al. Five siRNAs targeting SNPs may provide therapy for three-quarters of Huntington's disease patients. Curr. Biol. 19 (2009) 774-778
83. Antic D., et al. ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in teratocarcinoma cells. Genes Dev. 13 (1999) 449-461
84. Bomsztyk K., et al. hnRNP K: one protein multiple processes. BioEssays 26 (2004) 629-638
85. Liu Y., et al. A crucial role for hnRNP K in axon development in Xenopus laevis. Development 135 (2008) 3125-3135
86. Yano M., et al. Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation. J. Biol. Chem. 280 (2005) 12690-12699
87. Irwin N., et al. Identification of two proteins that bind to a pyrimidine-rich sequence in the 3′-untranslated region of GAP-43 mRNA. Nucleic Acids Res. 25 (1997) 1281-1288
88. Ostareck D.H., et al. Lipoxygenase mRNA silencing in erythroid differentiation: the 3′UTR regulatory complex controls 60S ribosomal subunit joining. Cell 104 (2001) 281-290
89. Habelhah H., et al. ERK phosphorylation drives cytoplasmic accumulation of hnRNP K and inhibition of mRNA translation. Nat. Cell Biol. 3 (2001) 325-330
90. Moore M.J. From birth to death: the complex lives of eukaryotic mRNAs. Science 309 (2005) 1514-1518
91. Zalfa F., and Bagni C. Molecular insights into mental retardation: multiple functions for the Fragile X mental retardation protein?. Curr. Issues Mol. Biol. 6 (2004) 73-88
92. Lin A.C., and Holt C.E. Function and regulation of local axonal translation. Curr. Opin. Neurobiol. 18 (2008) 60-68
93. Keene J.D., and Tenenbaum S.A. Eukaryotic mRNPs may represent posttranscriptional operons. Mol. Cell 9 (2002) 1161-1167
94. Perrot R., et al. Axonal neurofilaments control multiple fiber properties but do not influence structure or spacing of nodes of Ranvier. J. Neurosci. 27 (2007) 9573-9584
95. Herrmann H., and Aebi U. Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular scaffolds. Annu. Rev. Biochem. 73 (2004) 749-789
96. Herrmann H., et al. Intermediate filaments: from cell architecture to nanomechanics. Nat. Rev. Mol. Cell Biol. 8 (2007) 562-573
97. Ge W., et al. Binding of p190RhoGEF to a destabilizing element on the light neurofilament mRNA is competed by BC1 mRNA. J. Biol. Chem. 277 (2002) 42701-42705
98. Perrot R., and Eyer J. Neuronal intermediate filaments and neurodegenerative disorders. Brain Res. Bull. 80 (2009) 282-295
99. Mersiyanova I.V., et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet. 67 (2000) 37-46
100. De Jonghe P., et al. Further evidence that neurofilament light chain mutations can cause Charcot-Marie-Tooth disease type 2E. Ann. Neurol. 49 (2001) 245-249
101. Brownlees J., et al. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum. Mol. Gen. 11 (2002) 2837-2844
102. Perez-Olle R., et al. Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport. J. Neurochem. 93 (2005) 861-874
103. Schmidt M.L., et al. Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary tangles. Am. J. Pathol. 136 (1990) 1069-1075
104. Bigio E.H., et al. Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol. Appl. Neurobiol. 29 (2003) 239-253
105. Cairns N.J., et al. a-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative disease. Acta Neuropathol. 108 (2004) 213-223
106. Bomont P., et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat. Genet. 26 (2000) 370-374
107. Bousquet O., et al. Aggregation of a subpopulation of vimentin filaments in cultured human skin fibroblasts derived from patients with giant axonal neuropathy. Cell Motil. Cytoskeleton 33 (1996) 115-129
108. Buissonniere R.F., et al. Giant axonal neuropathy: intermediate filament disease with involvement of the peripheral and central nervous system. Rev. Neurol. 145 (1989) 355-361
109. Yagihashi S., et al. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats. Am. J. Pathol. 136 (1990) 1365-1373